Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein
AUTOR(ES)
Roboti, Peristera
FONTE
Company of Biologists
RESUMO
Missense mutations in human PLP1, the gene encoding myelin proteolipid protein (PLP), cause dysmyelinating Pelizaeus-Merzbacher disease of varying severity. Although disease pathology has been linked to retention of misfolded PLP in the endoplasmic reticulum (ER) and induction of the unfolded protein response (UPR), the molecular mechanisms that govern phenotypic heterogeneity remain poorly understood. To address this issue, we examined the cellular response to missense mutants of PLP that are associated with distinct disease phenotypes. We found that the mild-disease-associated mutants, W162L and G245A, were cleared from the ER comparatively quickly via proteasomal degradation and/or ER exit. By contrast, the more `aggressive' A242V mutant, which causes severe disease, was significantly more stable, accumulated at the ER and resulted in a specific activation of the UPR. On the basis of these findings, we propose that the rate at which mutant PLP proteins are cleared from the ER modulates disease severity by determining the extent to which the UPR is activated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2773193Documentos Relacionados
- Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum
- Altered protein dynamics of disease-associated lamin A mutants
- A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin
- Protein quality control—linking the unfolded protein response to disease: Conference on ‘From Unfolded Proteins in the Endoplasmic Reticulum to Disease'
- The functional importance of disease-associated mutation